Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
A constitutive pan-hexose permease for the Plasmodium life cycle and transgenic models for screening of antimalarial sugar analogs.
Blume M
,
Hliscs M
,
Rodriguez-Contreras D
,
Sanchez M
,
Landfear S
,
Lucius R
,
Matuschewski K
,
Gupta N
.
???displayArticle.abstract???
Glucose is considered essential for erythrocytic stages of the malaria parasite, Plasmodium falciparum. Importance of sugar and its permease for hepatic and sexual stages of Plasmodium, however, remains elusive. Moreover, increasing global resistance to current antimalarials necessitates the search for novel drugs. Here, we reveal that hexose transporter 1 (HT1) of Plasmodium berghei can transport glucose (K(m)~87 μM), mannose (K(i)~93 μM), fructose (K(i)~0.54 mM), and galactose (K(i)~5 mM) in Leishmania mexicana mutant and Xenopus laevis; and, therefore, is functionally equivalent to HT1 of P. falciparum (Glc, K(m)~175 μM; Man, K(i)~276 μM; Fru, K(i)~1.25 mM; Gal, K(i)~5.86 mM). Notably, a glucose analog, C3361, attenuated hepatic (IC(50)~15 μM) and ookinete development of P. berghei. The PbHT1 could be ablated during intraerythrocytic stages only by concurrent complementation with PbHT1-HA or PfHT1. Together; these results signify that PbHT1 and glucose are required for the entire life cycle of P. berghei. Accordingly, PbHT1 is expressed in the plasma membrane during all parasite stages. To permit a high-throughput screening of PfHT1 inhibitors and their subsequent in vivo assessment, we have generated Saccharomyces cerevisiae mutant expressing codon-optimized PfHT1, and a PfHT1-dependent Δpbht1 parasite strain. This work provides a platform to facilitate the development of drugs against malaria, and it suggests a disease-control aspect by reducing parasite transmission.
Blume,
Host-derived glucose and its transporter in the obligate intracellular pathogen Toxoplasma gondii are dispensable by glutaminolysis.
2009, Pubmed
Blume,
Host-derived glucose and its transporter in the obligate intracellular pathogen Toxoplasma gondii are dispensable by glutaminolysis.
2009,
Pubmed
Burchmore,
Genetic characterization of glucose transporter function in Leishmania mexicana.
2003,
Pubmed
Daily,
Distinct physiological states of Plasmodium falciparum in malaria-infected patients.
2007,
Pubmed
Desai,
A nutrient-permeable channel on the intraerythrocytic malaria parasite.
1993,
Pubmed
Dondorp,
Artemisinin resistance: current status and scenarios for containment.
2010,
Pubmed
Feistel,
An expression system to screen for inhibitors of parasite glucose transporters.
2008,
Pubmed
Friesen,
Natural immunization against malaria: causal prophylaxis with antibiotics.
2010,
Pubmed
Fry,
Mitochondria of mammalian Plasmodium spp.
1991,
Pubmed
Gowda,
Glycosylphosphatidylinositol anchors represent the major carbohydrate modification in proteins of intraerythrocytic stage Plasmodium falciparum.
1997,
Pubmed
Gupta,
Selective disruption of phosphatidylcholine metabolism of the intracellular parasite Toxoplasma gondii arrests its growth.
2005,
Pubmed
Janse,
High efficiency transfection of Plasmodium berghei facilitates novel selection procedures.
2006,
Pubmed
Joet,
Validation of the hexose transporter of Plasmodium falciparum as a novel drug target.
2003,
Pubmed
,
Xenbase
Kirk,
Glucose uptake in Plasmodium falciparum-infected erythrocytes is an equilibrative not an active process.
1996,
Pubmed
Lasonder,
Proteomic profiling of Plasmodium sporozoite maturation identifies new proteins essential for parasite development and infectivity.
2008,
Pubmed
Lim,
The carbon and energy sources of the non-photosynthetic plastid in the malaria parasite.
2010,
Pubmed
Olszewski,
Branched tricarboxylic acid metabolism in Plasmodium falciparum.
2010,
Pubmed
Roth,
Malarial parasite hexokinase and hexokinase-dependent glutathione reduction in the Plasmodium falciparum-infected human erythrocyte.
1987,
Pubmed
Roth,
The enzymes of the glycolytic pathway in erythrocytes infected with Plasmodium falciparum malaria parasites.
1988,
Pubmed
Sachs,
The economic and social burden of malaria.
2002,
Pubmed
Sanchez,
Functional expression and characterization of a purine nucleobase transporter gene from Leishmania major.
2004,
Pubmed
,
Xenbase
Schuster,
Cultivation of plasmodium spp.
2002,
Pubmed
Seeber,
Apicomplexan mitochondrial metabolism: a story of gains, losses and retentions.
2008,
Pubmed
Seyfang,
Four conserved cytoplasmic sequence motifs are important for transport function of the Leishmania inositol/H(+) symporter.
2000,
Pubmed
,
Xenbase
Sidén-Kiamos,
Distinct roles for pbs21 and pbs25 in the in vitro ookinete to oocyst transformation of Plasmodium berghei.
2000,
Pubmed
Slavic,
Life cycle studies of the hexose transporter of Plasmodium species and genetic validation of their essentiality.
2010,
Pubmed
,
Xenbase
Tsuji,
Demonstration of heat-shock protein 70 in the sporozoite stage of malaria parasites.
1994,
Pubmed
Vaidya,
Mitochondrial evolution and functions in malaria parasites.
2009,
Pubmed
Vander Jagt,
D-lactate production in erythrocytes infected with Plasmodium falciparum.
1990,
Pubmed
Wieczorke,
Characterisation of mammalian GLUT glucose transporters in a heterologous yeast expression system.
2003,
Pubmed
Wieczorke,
Concurrent knock-out of at least 20 transporter genes is required to block uptake of hexoses in Saccharomyces cerevisiae.
1999,
Pubmed
Woodrow,
Hexose permeation pathways in Plasmodium falciparum-infected erythrocytes.
2000,
Pubmed
,
Xenbase
Woodrow,
Intraerythrocytic Plasmodium falciparum expresses a high affinity facilitative hexose transporter.
1999,
Pubmed
,
Xenbase
Youk,
Growth landscape formed by perception and import of glucose in yeast.
2009,
Pubmed
van Dooren,
Metabolic maps and functions of the Plasmodium mitochondrion.
2006,
Pubmed
